May reduce the absorption of concomitantly administered oral medications. Administer oral medications at least 2 hours before or 2 hours after administration of lactitol.
- TRADE NAME: Pizensy (Braintree Labs)
- INDICATIONS: Treatment of chronic idiopathic constipation in adults
- CLASS: Laxative
- HALF-LIFE: 2.4 hours
- FDA APPROVAL DATE: 02/12/2020
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
